Pricing Log in Create free account

BioVie Inc. (BIVI) vs Lipocine Inc. (LPCN)

BioVie Inc. and Lipocine Inc. are both Biotechnology companies. Lipocine Inc. is the larger, with a market value of $12.6M against $10.3M — 1.2× the size. BioVie Inc. has the higher net margin (0.00% vs −249.2%) and the lower return on invested capital (−1,095.0% vs 0.00%). Across the 13 metrics below, Lipocine Inc. leads on 8 and BioVie Inc. on 5.

Valuation

Metric BIVI LPCN Biotechnology median
P/E n/m n/m 10.26
P/S n/m 3.37 9.18
P/B 0.85 0.60 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.58 0.65
EV/Sales n/m (1.58) 8.98
Earnings yield (260.33%) (88.89%) (34.89%)
Free cash flow yield (216.99%) (80.16%) (24.52%)

Profitability

Metric BIVI LPCN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (269.05%) 0.00%
Net margin 0.00% (249.16%) 0.00%
Free cash flow margin 0.00% (267.37%) 0.00%
Return on equity (151.06%) (52.86%) (50.12%)
Return on assets (123.51%) (47.52%) (45.60%)
Return on invested capital (1,095.01%) 0.00% 0.00%

Growth

Metric BIVI LPCN Biotechnology median
Revenue growth (TTM) — (13.36%) 6.26%
EPS growth (last fiscal year) 74.83% (93,988.89%) 29.88%
Revenue growth, 5-year CAGR — 64.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI LPCN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.59 11.36 4.89
Net debt to EBITDA 0.40 1.42 1.01

Dividend

Metric BIVI LPCN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BIVI LPCN Biotechnology median
Market cap 10.32m 12.61m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack